Biotech Market Intelligence & Analysis
In-depth articles on the biotech landscape — market analysis, sector reports, funding trends, and company spotlights.
CRISPR Gene Editing Companies: Who's Leading the Revolution
The year 2026 is poised to be a landmark year for CRISPR-based gene editing, marking a critical transition from a revolutionary laboratory tool to a validated, commercialized therapeutic platform. The field is no longer defined by speculative potential but by tangible, regulatory
The Complete Guide to CAR-T Therapy Companies
Chimeric Antigen Receptor T-cell (CAR-T) therapy represents one of the most profound breakthroughs in modern oncology. By genetically reprogramming a patient’s own immune cells to hunt down and destroy cancer, this living drug has shifted the treatment paradigm for certain intrac
Top 50 Biotech Companies by Market Cap in 2026
As we look at the biotech landscape in 2026, the data reveals a seismic shift in global power dynamics. The traditional dominance of Western pharmaceutical giants has been decisively challenged, and in many cases, overtaken, by a wave of Asian biotech and pharmaceutical companies